产品详情
Targets
Target | Value |
---|---|
Akt2 | IC50: 17nM |
PKA | IC50: 20nM |
Akt1 | IC50: 32nM |
Akt3 | IC50: 47nM |
p70S6K | IC50: 85nM |
RSK1 | IC50: >100nM |
CDK2 | IC50: >1μM |
GSK-3β | IC50: >1μM |
c-Src | IC50: >1μM |
Chk1 | IC50: >1μM |
EGFR | IC50: >1μM |
FGFR3 | IC50: >1μM |
MEK1 | IC50: >1μM |
PDK-1 | IC50: >1μM |
PI3Kβ | IC50: >1μM |
PLK3 | IC50: >1μM |
RET | IC50: >1μM |
SGK | IC50: >1μM |
Tie-2 | IC50: >1μM |
In vitro (25°C) | DMSO | 63 mg/mL (186.47 mM) | |
Water | Insoluble | ||
Ethanol | 5 mg/mL (14.79 mM) | ||
In vivo | 15% Captisol, pH 9 | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 29.59 mL | 147.97 mL | 295.95 mL |
0.5 mM | 5.92 mL | 29.59 mL | 59.19 mL |
1 mM | 2.96 mL | 14.8 mL | 29.59 mL |
5 mM | 0.59 mL | 2.96 mL | 5.92 mL |
*The above data is based on the productmolecular weight 337.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10094 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 337.9 |
Formula | C20H20ClN3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 857531-00-1 |
Synonyms | AT-7867 |
SMILES | C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl |
产品标签
Product Questions
Product Questions
Palomid 529 (P529)
Palomid 529是PI3K/Akt/mTOR途径的双重TORC1/2抑制剂,在血管生成和细胞增殖中具有广泛的活性。
10-DEBC HCl
10-DEBC HCl是Akt/PKB的选择性抑制剂。它抑制IGF-1刺激的磷酸化和Akt的激活(在2.5μM时完全抑制),抑制mTOR,p7…
AKT inhibitor VIII (AKTI-1/2)
AKT inhibitor VIII (AKTI-1/2)是一种细胞可渗透且可逆的喹喔啉化合物,在体外激酶测定中,该化合物有效和选择…
MK-2206 2HCl
MK-2206 2HCl是Akt1/2/3的高选择性抑制剂,IC50分别为8 nM/12 nM/65 nM。
TIC10 isomer
TIC10通过Foxo3a使Akt和ERK失活,从而诱导TRAIL,具有优越的药物特性:跨血脑屏障传递,优异的稳定性和改善…
GSK2141795 (Uprosertib, GSK795)
GSK2141795 (Uprosertib,GSK795)结合并抑制Akt的活性,这可能导致PI3K/Akt信号传导途径的抑制和肿瘤细胞的增殖以及…